Journal Mobile Options
Table of Contents
Vol. 30, No. 2, 2011
Issue release date: September 2011
Fetal Diagn Ther 2011;30:157–159

Pre- and Postnatal Imaging of a Congenital Hepatoblastoma

Al-Hussein H.A. · Graham E.M. · Tekes A. · Huisman T.A.G.M.
aDivision of Pediatric Radiology, Russell H. Morgan Department of Radiology and Radiological Science, bDivision of Maternal-Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, Md., USA; cAl Sadder General Hospital, Missian, Iraq

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Prenatal ultrasound, magnetic resonance imaging and matching postnatal computer tomography imaging findings are presented in a neonate with histologically proven congenital hepatoblastoma. Familiarity with the prenatal imaging findings of a hepatoblastoma are essential to make a reliable, specific diagnosis facilitating decision-making about the pre-, peri- and postnatal management.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Siegel MJ: Pediatric liver magnetic resonance imaging. Magn Reson Imaging Clin N Am 2002;10:253–273.
  2. DeBaun MR, Tucker MA: Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann syndrome registry. J Pediatr 1998;132:398–400.
  3. Giardiello FM, Offerhaus GJ, Krush AJ et al: Risk of hepatoblastoma in familial adenomatosis polyposis. J Pediatr 1991;119:766–768.
  4. Finegold MJ: Liver tumors; in Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Walkin JB (eds): Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. Hamilton, Decker, 1991, pp 914–926.
  5. Ortega JA, Krailo MD, Hass JE, et al: Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Children’s Cancer Study Group. J Clin Oncol 1991;9:2167–2176.

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00